Overall rank by patents
#26,177
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 22 technology areas, active 2017–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).
The verdict
Ecole holds 10 US patents across 22 technology areas, rank #26,177 of 50,000 tracked assignees.
Ecole Nationale Superieure DE Chimie DE Paris has been granted 10 US utility patents between 2017 and 2025, placing Ecole Nationale Superieure DE Chimie DE Paris at rank #26,177 across all assignees tracked by PlainPatent. This portfolio spans 22 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.7 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, Ecole Nationale Superieure DE Chimie DE Paris is one of the more focused assignees in the PatentsView dataset. By volume, Ecole sits between E.m.w. Energy Co., Ltd. (10 patents, rank #26,173) and Eggtronic Engineering S.r.l. (10 patents, rank #26,181) - the closest US assignees by grant volume. The composite Innovation Score of 54.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 9 grants, compared with 1 in the 2015–2019 window, a +800% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Ecole Nationale Superieure DE Chimie DE Paris's 15.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 22 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ecole Nationale Superieure DE Chimie DE Paris against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
E.M.W. ENERGY CO., LTD.
10 patents
EAGLE HARBOR HOLDINGS, LLC
10 patents
EASY SANITARY SOLUTIONS B.V.
10 patents
EATON INDUSTRIAL CORPORATION
10 patents
ECOLE NATIONALE SUPERIEURE DE MECANIQUE ET DES MICROTECHNIQUES (ENSMM)
10 patents
ECU TECHNOLOGY, LLC
10 patents
EDGE2020 LLC
10 patents
EGGTRONIC ENGINEERING S.R.L.
10 patents
ECOLE NATIONALE SUPERIEURE DE CHIMIE DE PARIS
10 patents
What this shows Ecole holds 10 patents at rank #26,177, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Ecole's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
54 Top 8% higher than 92% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 10.0% |
| 2022 | 4 | 40.0% |
| 2023 | 1 | 10.0% |
| 2024 | 3 | 30.0% |
| 2025 | 1 | 10.0% |
Top 15 of 22 technology areas
Overall rank by patents
#26,177
Across all tracked assignees
54.3 out of 100
How to use this portfolio
Ecole's 10 grants land it in the top 8% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.